FDA Compliance for Peptide Therapy and BPC 157 Holt Law A Note on Peptides by Shantanu Out of Singapore The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest